Pluriomics
Latest round
- Series A
Last raised
- Oct 2014
Total raised
- $5M
Investors
- 3
About Pluriomics
V.V. specializes in iPSC technology.V. develops human induced pluripotent stem cells (iPSCs) and related technologies designed to enhance drug discovery and development.V. generates revenue through direct B2B transactions with drug developers and researchers. Their services encompass custom iPSC reprogramming, gene editing, and differentiation services, which are typically arranged as project-based contracts.V. aims to expand its product offerings and enhance existing technologies. The company is exploring new markets across Europe and Asia, with plans to launch additional iPSC-based products by the end of 2024.
Who invested in Pluriomics
3 investors across 1 round
See all investors in Pluriomics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 15, 2014
Amount
$5M
Investors
Questions about Pluriomics
Who invested in Pluriomics?
Pluriomics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pluriomics raised?
Pluriomics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Pluriomics last raise money?
Pluriomics's most recent round on record is a Series A, in Oct 2014.
What does Pluriomics do?
Pluriomics is a biotechnology company.
Where is Pluriomics headquartered?
Pluriomics is headquartered in Leiden, Netherlands.
Which VCs invest in companies like Pluriomics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Pluriomics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Pluriomics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.